The Deal Pipeline reports Fried Frank's role in Penwest's acquisition by Endo Pharmaceuticals

The Deal Pipeline reports Fried Frank's role in Penwest's acquisition by Endo Pharmaceuticals

The Deal Pipeline reported the Firm’s represented BofA Merrill Lynch as exclusive financial advisor to Penwest Pharmaceuticals in connection with Penwest's acquisition by Endo Pharmaceuticals. The publication noted corporate partner Philip Richter (NY) and tax partner Alan S. Kaden’s (DC) roles on the matter.

news-detail.inc